1. Home
  2. BOC vs SRDX Comparison

BOC vs SRDX Comparison

Compare BOC & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOC
  • SRDX
  • Stock Information
  • Founded
  • BOC 2009
  • SRDX 1979
  • Country
  • BOC United States
  • SRDX United States
  • Employees
  • BOC N/A
  • SRDX N/A
  • Industry
  • BOC
  • SRDX Medical/Dental Instruments
  • Sector
  • BOC
  • SRDX Health Care
  • Exchange
  • BOC Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • BOC 431.5M
  • SRDX 415.4M
  • IPO Year
  • BOC 2017
  • SRDX 1998
  • Fundamental
  • Price
  • BOC $13.56
  • SRDX $34.15
  • Analyst Decision
  • BOC Buy
  • SRDX Buy
  • Analyst Count
  • BOC 2
  • SRDX 3
  • Target Price
  • BOC $20.00
  • SRDX $43.00
  • AVG Volume (30 Days)
  • BOC 225.9K
  • SRDX 342.3K
  • Earning Date
  • BOC 08-13-2025
  • SRDX 08-08-2025
  • Dividend Yield
  • BOC N/A
  • SRDX N/A
  • EPS Growth
  • BOC N/A
  • SRDX N/A
  • EPS
  • BOC 0.02
  • SRDX N/A
  • Revenue
  • BOC $111,568,551.00
  • SRDX $120,801,000.00
  • Revenue This Year
  • BOC $9.19
  • SRDX N/A
  • Revenue Next Year
  • BOC $6.50
  • SRDX $3.38
  • P/E Ratio
  • BOC $649.55
  • SRDX N/A
  • Revenue Growth
  • BOC 9.53
  • SRDX N/A
  • 52 Week Low
  • BOC $12.27
  • SRDX $26.00
  • 52 Week High
  • BOC $16.20
  • SRDX $40.39
  • Technical
  • Relative Strength Index (RSI)
  • BOC 55.85
  • SRDX 43.47
  • Support Level
  • BOC $12.42
  • SRDX $34.99
  • Resistance Level
  • BOC $13.76
  • SRDX $37.77
  • Average True Range (ATR)
  • BOC 0.35
  • SRDX 1.54
  • MACD
  • BOC 0.10
  • SRDX -0.54
  • Stochastic Oscillator
  • BOC 86.58
  • SRDX 3.28

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: